Morgan Stanley
CVET

Morgan Stanley’s Covetrus, Inc. Common Stock CVET Stock Holding History

Morgan Stanley’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,404,876
Closed -$29.3M – 8166
2022
Q3 		$29.3M Buy
1,404,876
+493,644
+54% +$10.3M ﹤0.01% 1796
2022
Q2 		$18.9M Sell
911,232
-722,886
-44% -$12.9M ﹤0.01% 2355
2022
Q1 		$27.4M Sell
1,634,118
-2,357,842
-59% -$41.2M ﹤0.01% 1789
2021
Q4 		$79.7M Sell
3,991,960
-4,806,989
-55% -$90.5M 0.01% 1031
2021
Q3 		$160M Sell
8,798,949
-2,520,796
-22% -$57.8M 0.02% 614
2021
Q2 		$306M Buy
11,319,745
+145,888
+1% +$4.08M 0.04% 400
2021
Q1 		$335M Buy
11,173,857
+175,090
+2% +$5.97M 0.05% 327
2020
Q4 		$316M Buy
10,998,767
+1,714,264
+18% +$46.3M 0.05% 335
2020
Q3 		$227M Sell
9,284,503
-2,585,607
-22% -$55.8M 0.04% 348
2020
Q2 		$212M Sell
11,870,110
-263,310
-2% -$3.46M 0.05% 338
2020
Q1 		$98.8M Sell
12,133,420
-240,125
-2% -$2.74M 0.03% 493
2019
Q4 		$163M Buy
12,373,545
+1,105,407
+10% +$13.4M 0.04% 438
2019
Q3 		$134M Sell
11,268,138
-163,655
-1% -$3.03M 0.04% 457
2019
Q2 		$280M Buy
11,431,793
+908,848
+9% +$26.2M 0.07% 267
2019
Q1 		$335M Buy
+10,522,945
New +$373M 0.09% 221

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's CVET Position: Q4 2022 in Review

Morgan Stanley sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,404,876 shares — an estimated $29.3M sold.

Morgan Stanley first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $335M in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Morgan Stanley reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 1,404,876 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $29.3M.
  • Morgan Stanley first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Morgan Stanley's Covetrus, Inc. Common Stock position peaked at $335M in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.